European regulators have approved Moderna Inc.’s novel combination flu and Covid shot, handing a victory to the embattled ...

The February 2026 meeting of the EMA's Committee for Medicinal Products for Human Use (CHMP) resulted in recommendations for twelve new medicines.¹ These outcomes, which included recommendations for ...

Q. My husband got COVID last fall. He has had great success from Paxlovid in the past, when he got it for free during the pandemic. This time he was charged $800 on his Medicare Drug Plan. That seems ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsAndrew Guggenhime - President & CFOGrant Pickering ...

Blackstone Life Sciences announced a research and development funding agreement to advance the clinical development of bleximenib, an investigational oral menin inhibitor, for acute myeloid leukemia ...

- Advancement reflects continued execution of capital-efficient development strategy leveraging POZ Platform™ - ...

Blinded evaluation of safety and tolerability data by the Safety Monitoring Committee from Cohort 1 and advancement to Cohort 2 is expected in 3Q 2026 - - Advancement reflects continued execution of ...

The global biopharmaceuticals market is projected to grow at a compound annual growth rate (CAGR) of approximately 12% over ...

This new filing is not an isolated event but represents another front in a protracted legal war between the two biotech firms. The conflict has a precedent: Moderna originally sued both BioNTech and ...

Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of ...

The committee’s reputation has taken a nosedive, however, following HHS Secretary Robert F. Kennedy Jr.’s decision to purge ...